Dr. V. Kohila

Assistant Professor

Department of Biotechnology

National Institute of Technology, Warangal - 506004, Telangana, INDIA

: v.kohila@nitw.ac.in

: 8332969460

Interests: Gene therapy, Molecular biology, Immunology, Bioinformatics


Gene therapy for cancer and rheumatoid arthritis; Bioinformatics


  1. PhD, Biotechnology: 2014, IIT Guwahati.
  2. M.Tech, Biotechnology: 2008, WBUT, Kolkata.
  3. B.Tech, Biotechnology: 2006, MEPCO, Anna University, Chennai.

Positions Held:

  1. Assistant Professor, NIT Warangal, September 2013- till date.
  2. Faculty (Adhoc), NIT Warangal, Mar- Aug, 2013.





Course Taught Previously


Course Taught Previously:

ClassDepartmentSemesterCourse IDCourse Name
III B. Tech Biotechnology VI BT363 Medical biotechnology
II B. Tech Biotechnology IV BT254 Molecular Biology & Genetics Lab
III B. Tech Biotechnology V BT301 Immunology
III B. Tech Biotechnology V BT304 Immunology Lab
I B. TechSection AIIBT101Engineering Biology


Courses Currently Being Taught:

ClassDepartmentSemesterCourse IDCourse Name
IV  B. TechBiotechnologyVIIIBT465Genomics and Proteomics
II B. TechBiotechnologyIVBT256Molecular Biology Labaratory


Journal Publications:


1. R. Kowshik Aravilli, S. Laveen Vikram, V. Kohila*. Phytochemicals as potential antidotes for targeting NF-kappaB in rheumatoid arthritis. 3 biotech, 2017, 7:253. [Springer publications]

2. Raza MA, V. Kohila, Ghosh SS. Redesigned E. coli cytosine deaminase: a new facet of suicide gene therapy. J Gene Med, 2015, 17, 132-139. [John Wiley & sons Ltd]

3. V. Kohila, Amit Jaiswal, Siddhartha Sankar Ghosh. Rationally designed Escherichia coli cytosine deaminase mutants with improved specificity towards the prodrug 5-fluorocytosine for potential gene therapy applications. Med. Chem. Commun., 2012, 3, 1316-1322. [RSC publications]

PHDs Supervised

Mr. R. Kowshik Aravilli (Full time scholar) - July 2014 - till date



Conferences/Workshops attended:

AuthorTitleConference NamePlace
R. Kowshik Aravilli, V. Kohila*Redesigned hGSTM1- an antidote to oxidative stressRecent Advancements in Biochemical Engineering and Biotechnology (RABEB-2019), 15-16 March, 2019).  [Poster Presentation]IIT BHU, Varanasi
R. Kowshik Aravilli, V. Kohila*In silico redesigning of hGSTM1 towards suppression of oxidative stress in rheumatoid arthritisInternational Conference on Advances in Biotechnology and Biotherapeutics (ICABBS-2017), 8-10 March, 2017.  [Poster Presentation]Sathyabama University, Chennai. 
V. Kohila*
Solar driven water disinfection by ozonization using phytoplankton: An overview
International Conference on Innovations in Sustainable Water & Waste water Treatment Systems (ISWATS-2016), 21-23 April, 2016. [Poster Presentation]
V. Kohila*
Restructured Rubisco for enhanced biosequestration of carbon dioxide by effective bioprecipitation of calcium carbonateInternational Conference on Recent Trends in Biosciences (ICRTB-2016),  7-9 April 2016. [Poster Presentation; Awarded Second Prize]Alagappa University, Karaikudi.
R. Kowshik Aravilli, V. Kohila*In silico modeling of hGSTM1 to suppress inflammation in rheumatoid arthritisInternational Conference and Workshop on structure based drug designing and application to infectious diseases, 1-5 February, 2016. [Poster Presentation]HCU, Hyderabad.
Asif raza, V. Kohila, Siddhartha Sankar Ghosh.
Application of redesigned E. coli cytosine deaminase in the perspective of cancer
5th International Conference on Stem Cells and Cancer (ICSCC-2014): Proliferation, Differentiation and Apoptosis, 8-11 November, 2014. [Poster Presentation]
JNU, New Delhi.
 V. Kohila, Siddhartha Sankar Ghosh.The Emergence of E. coli Uracil PhosphoRibosylTransferase mutants in the prospect of cancer therapeutics: a Bioinformatics Approach.International Symposium on Bioengineering (ISBE-2012). [Poster Presentation]IIT Guwahati
 V. Kohila, Amit Jaiswal, Siddhartha Sankar Ghosh.

Redesigning of E. coli cytosine deaminase in the perspective of cancer therapeutics.

 3rd International Conference on Stem Cells and Cancer: Proliferation, Differentiation and Apoptosis (ICSCC- 2012), 27-30 October, 2012. [Poster Presentation; Best Poster Award]
PGIMER, Dr Ram Manohar Lohia Hospital, New Delhi



 R & D Project I (Sanctioned):

Title: "Anti-inflammatory effect of a novel fusion suicide gene bCDS126R-hGST on rheumatoid arthritis".

 PI: Dr. V. Kohila

Co-PI: Dr. Amit jaiswal, Assistant Professor, IIT Mandi.

Funding Agency: ICMR, Govt. of India

Sanctioned Amount: Rs. 21,38,500

Period of Support: 2017-20


 R & D Project II (Ongoing):

Title: "Cytotoxic and tumor suppressor role of a novel fusion suicide gene bCDF186W-hPFN1 on rheumatoid arthritis".

 PI: Dr. V. Kohila

Funding Agency: DST-SERB, Govt. of India

Sanctioned Amount: Rs. 39,21,000

Period of Support: 2017-20


Awards and Honors


Awards and Honours:

1. Qualified Combined Entrance Examination for Biotechnology (CEEB), 2006, conducted by Jawaharlal Nehru University (JNU), New Delhi, India.
2. Qualified Department of Biotechnology Junior Research Fellowship (DBT-JRF), 2008.
3. University rank holder (Second) in M.Tech (2008), WBUT.

4. MHRD fellowship to pursue PhD at IIT Guwahati.

Additional Responsibility

Departmental responsibilities:

Faculty In-charge, III B.Tech Biotechnology from 2015 - May 2018

Departmental Time table In-charge from July  2017 - Dec 2017

Departmental Internet & Telecom In-charge from May 2018  - till date

Institute Responsibilities:

Ladies hostel warden (Priyadarshini hall) from Nov 2018 - till date